The role and mechanism of CHMP4C in poor prognosis and drug sensitivity of lung adenocarcinoma
Abstract Background Chromatin modified protein 4C (CHMP4C) is a charged polyvesicular protein (CHMP) that is involved in the composition of the endosomal sorting complex (ESCRT-III) required for transport III and promotes the necessary separation of daughter cells. CHMP4C involved in a wide variety...
Saved in:
| Main Authors: | Chuan Xu, Mingshan Liu, Yang Li, Xiaoyue Peng, Wei Zhou, Wan Zhang, Jingtao Zhang, Bentong Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-03-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-01986-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CHMP6 as a novel prognostic biomarker in bladder cancer: insights from a comprehensive cell death-related gene risk model
by: Wei Ning, et al.
Published: (2025-06-01) -
EXOSC5: a novel biomarker for poor prognosis in lung adenocarcinoma
by: Jianxun Xu, et al.
Published: (2025-04-01) -
Identification of biomarkers based on ubiquitin-correlated genes for predicting immune profile and drug sensitivity in lung adenocarcinoma
by: Yue Li, et al.
Published: (2025-08-01) -
The ESCRT protein CHMP5 restricts bone formation by controlling endolysosome-mitochondrion-mediated cell senescence
by: Fan Zhang, et al.
Published: (2025-07-01) -
The lysosome-related characteristics affects the prognosis and tumor microenvironment of lung adenocarcinoma
by: Wuguang Chang, et al.
Published: (2025-01-01)